企業プロフィール
Idera 株価・ニュース・カタリスト
- ティッカー:
- IDRA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for IDRA.
企業概要
事業概要
Idera Pharmaceuticals is a historical small-cap biotechnology name associated with immunology and oncology programs, including work around innate immune pathways. The company has long been a legacy example of a narrow pipeline trying to create value in a very competitive biotech market.
所在地とセクター分類
Idera is headquartered in the United States and listed on NASDAQ, with a profile that has historically sat in small-cap biotech. It belongs more to the legacy development group than to a large commercial franchise.
ビジネスモデルの特徴
The business model was defined by clinical development, capital preservation, and the ability to keep a focused pipeline alive long enough to generate value. Investors historically watched data updates, restructuring activity, and financing runway.
バイオ業界での位置付け
Idera sits in the historical category of high-risk micro-cap biotech names. It is best understood as a legacy development story where execution and financing risk were always dominant.
今後のカタリスト
- Idera is now largely a legacy / closeout story, so the catalysts are any asset-resolution update rather than a live pipeline readout. The company is mainly in wind-down mode.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。